← Browse by Condition
Medical Condition
hnscc
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 1, Phase 2
NCT06789172 Phase 1
Recruiting
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Enrollment
166 pts
Location
United States, Austr...
Sponsor
Epkin
NCT06915454
Recruiting
High-Resolution PET-CT Imaging for Surgical Margin Visualization
Enrollment
50 pts
Location
United States
Sponsor
Vanderbilt-Ingram Cancer Cente...
NCT07136545 Phase 1, Phase 2
Recruiting
A Phase I/II Trial of HCB101 in Combination With Pembrolizumab for Patients With Platinum-Refractory, Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (SirH&N Trial)
Enrollment
50 pts
Location
Taiwan
Sponsor
Taipei Veterans General Hospit...
NCT06016920 Phase 1, Phase 2
Recruiting
Safety and Efficacy of VB10.16 and Pembrolizumab in Patients with Head-Neck Squamous Cell Carcinoma
Enrollment
51 pts
Location
Czechia, France, Ger...
Sponsor
Nykode Therapeutics ASA